Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Progesterone supplementation during the two week wait is generally considered safe and is not known to harm an early pregnancy, since it supports the uterine lining rather than interfering with embryo development. Common effects such as bloating, breast tenderness, fatigue, spotting, or mild cramping come from the hormone itself and can mimic or mask early pregnancy signs, which is why timing, dosage, and delivery form (vaginal, oral, or injectable) matter. Stopping suddenly without medical guidance carries more risk than continuing, and progesterone will not prevent a loss caused by chromosomal issues. There are several important factors to consider, including who actually benefits from supplementation, so see below for the complete answer before making any changes.
If you are tracking symptoms in the two week wait and cannot tell what is hormone-related versus something that needs attention, a free, instant, online symptom check can help you organize what you are feeling, understand possible explanations, and decide whether to contact your clinician now or keep monitoring.
Last reviewed for medical accuracy: 09/17/2026
The “two-week wait” (2WW) is the time between ovulation (or embryo transfer) and when you can take a pregnancy test. Because progesterone is the hormone that prepares and maintains the uterine lining for implantation, many fertility specialists prescribe progesterone supplements during the 2WW. You may wonder: can adding extra progesterone do more harm than good?
Based on guidelines from the American College of Obstetricians and Gynecologists (ACOG), the European Society of Human Reproduction and Embryology (ESHRE), and multiple clinical trials, progesterone supplementation in the 2WW is generally considered safe and effective. Here’s what you need to know.
• Progesterone supports the “secretory” phase of your menstrual cycle, thickening the endometrium (uterine lining) so an embryo can implant.
• If your body doesn’t produce enough progesterone after ovulation (a luteal phase defect), the lining may break down too soon, risking early miscarriage.
• Studies of women undergoing in vitro fertilization (IVF) or timed intercourse show that progesterone supplementation improves implantation rates and reduces early pregnancy loss in those with low progesterone.
Overall safety
• Large reviews of luteal-phase support (including oral, vaginal, or intramuscular progesterone) find no increase in birth defects or long-term developmental issues in babies.
• ACOG endorses progesterone use when medically indicated, noting its safety profile over decades of research.
Possible side effects
Most women tolerate progesterone well, but some experience:
These side effects often mirror normal early-pregnancy symptoms. Serious adverse effects are rare. If you notice any of the following, contact your healthcare provider right away:
No evidence of increased miscarriage
• Far from causing harm, progesterone supplementation reduces the risk of early miscarriage in women with confirmed luteal phase deficiency.
• Randomized trials show that women who receive progesterone after IVF have higher live-birth rates than those who receive a placebo.
If you’re considering ways to support your progesterone levels naturally or under medical supervision, discuss these strategies with your doctor:
Medical approaches
Nutrition and lifestyle
Stress management
Complementary therapies
Monitoring and follow-up
It’s natural to scan for every twinge, spotting, or cramp—and wonder if it signals trouble. To help you decide when to seek care, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can guide you on whether your symptoms fall within normal ranges or merit prompt medical attention.
Always discuss any health concerns—especially serious or life-threatening symptoms—with a qualified physician. Contact your care team if you experience:
Remember: every body is unique. Your healthcare provider can tailor a plan—medications, lifestyle tweaks, and monitoring—to give you the best chance of a healthy pregnancy. If you’re ever unsure about a symptom or need guidance, try the free, online symptom check, using the doctor approved Ubie Symptom Checker. And for anything severe or life-threatening, speak to a doctor right away.
(References)
* Romero R, Conde-Agudelo A, Da Fonseca E, O'Brien JM, Cetingoz E, Creasy GW, Hassan SS, Nicolaides KH. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018 Feb;218(2):161-180. doi: 10.1016/j.ajog.2017.11.576. Epub 2017 Nov 17. PMID: 29157866; PMCID: PMC5987201.
* Coomarasamy A, Devall AJ, Cheed V, Harb H, Middleton LJ, Gallos ID, Williams H, Eapen AK, Roberts T, Ogwulu CC, Goranitis I, Daniels JP, Ahmed A, Bender-Atik R, Bhatia K, Bottomley C, Brewin J, Choudhary M, Crosfill F, Deb S, Duncan WC, Ewer A, Hinshaw K, Holland T, Izzat F, Johns J, Kriedt K, Lumsden MA, Manda P, Norman JE, Nunes N, Overton CE, Quenby S, Rao S, Ross J, Shahid A, Underwood M, Vaithilingam N, Watkins L, Wykes C, Horne A, Jurkovic D. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. N Engl J Med. 2019 May 9;380(19):1815-1824. doi: 10.1056/NEJMoa1813730. PMID: 31067371.
* Coomarasamy A, Harb HM, Devall AJ, Cheed V, Roberts TE, Goranitis I, Ogwulu CB, Williams HM, Gallos ID, Eapen A, Daniels JP, Ahmed A, Bender-Atik R, Bhatia K, Bottomley C, Brewin J, Choudhary M, Crosfill F, Deb S, Duncan WC, Ewer A, Hinshaw K, Holland T, Izzat F, Johns J, Lumsden MA, Manda P, Norman JE, Nunes N, Overton CE, Kriedt K, Quenby S, Rao S, Ross J, Shahid A, Underwood M, Vaithilingham N, Watkins L, Wykes C, Horne AW, Jurkovic D, Middleton LJ. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT. Health Technol Assess. 2020 Jun;24(33):1-70. doi: 10.3310/hta24330. PMID: 32609084; PMCID: PMC7355406.
* Practice Committees of the American Society for Reproductive Medicine and the Society for Reproductive Endocrinology and Infertility. Diagnosis and treatment of luteal phase deficiency: a committee opinion. Fertil Steril. 2021 Jun;115(6):1416-1423. doi: 10.1016/j.fertnstert.2021.02.010. Epub 2021 Apr 4. PMID: 33827766.
* Devall AJ, Papadopoulou A, Podesek M, Haas DM, Price MJ, Coomarasamy A, Gallos ID. Progestogens for preventing miscarriage: a network meta-analysis. Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD013792. doi: 10.1002/14651858.CD013792.pub2. Epub 2021 Apr 19. PMID: 33872382; PMCID: PMC8406671.
* Devine K, Richter KS, Jahandideh S, Widra EA, McKeeby JL. Intramuscular progesterone optimizes live birth from programmed frozen embryo transfer: a randomized clinical trial. Fertil Steril. 2021 Sep;116(3):633-643. doi: 10.1016/j.fertnstert.2021.04.013. Epub 2021 May 13. PMID: 33992421.
* Melo P, Chung Y, Pickering O, Price MJ, Fishel S, Khairy M, Kingsland C, Lowe P, Petsas G, Rajkhowa M, Sephton V, Tozer A, Wood S, Labarta E, Wilcox M, Devall A, Gallos I, Coomarasamy A. Serum luteal phase progesterone in women undergoing frozen embryo transfer in assisted conception: a systematic review and meta-analysis. Fertil Steril. 2021 Dec;116(6):1534-1556. doi: 10.1016/j.fertnstert.2021.07.002. Epub 2021 Aug 10. PMID: 34384594.
* Duncan WC. The inadequate corpus luteum. Reprod Fertil. 2021 Jan;2(1):C1-C7. doi: 10.1530/RAF-20-0044. Epub 2021 Feb 26. PMID: 35128435; PMCID: PMC8812462.
* Zarei A, Keshavarzi A, Zare M. Comparison of the duration of estradiol administration and the effect on pregnancy outcome of day 3 vitrified-warmed embryo transfer cycle: a randomized controlled trial. Zygote. 2023 Oct;31(5):491-497. doi: 10.1017/S096719942300031X. Epub 2023 Jul 14. PMID: 37448263.
* Rinaldi L, Crescenzi F, Selman H. Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial. BMC Pregnancy Childbirth. 2024 Dec 21;24(1):845. doi: 10.1186/s12884-024-07069-8. Epub 2024 Dec 21. PMID: 39709390; PMCID: PMC11662462.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.